Unlocking Trafficking Specificity for Cx43 Gap Junctions
解锁 Cx43 间隙连接的贩运特异性
基本信息
- 批准号:10377923
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsArrhythmiaBasic ScienceBiologicalBiologyCRISPR/Cas technologyCardiacCardiac MyocytesCardiac healthCardiovascular systemCellsClinicalCommunicationConnexin 43CouplingCytoskeletonDataDefectDevelopmentDiseaseGap JunctionsGoalsHeartHeart DiseasesHeart failureIntercalated discIon ChannelIschemiaIschemic PreconditioningLaboratoriesLengthLinkMembraneMembrane ProteinsMethionineMethodsMicrotubulesMolecularMorbidity - disease rateMovementMusMuscle CellsMyocardialN-terminalOutcomePathologicPathway interactionsPatternPharmacologyPoint MutationProtein IsoformsProteinsPublishingRegulationReportingResearchRoleScienceSpecificityStressTestingTherapeuticTimeTranslatingTranslationsUnited StatesUnited States National Institutes of HealthWorkbasebiological adaptation to stressexperimental studyin vivomortalitymouse modelnovelnovel diagnosticsnovel markernovel therapeutic interventionnovel therapeuticsorganelle movementpolymerizationpreservationprotein transportsudden cardiac deathtargeted deliverytooltrafficking
项目摘要
Disturbances in ion channel function is a fundamental aspect of the arrhythmias of sudden
cardiac death. Recently, there has been is increased appreciation that cardiac ion channels have very
short half lives, and much of disturbed ion channel function in disease results from altered trafficking
and altered localization to the appropriate subdomain. Regulation of intracellular trafficking remains
poorly understood for cardiac ion channels.
In previous studies, we have identified how Connexin43 (Cx43) gap junction hemichannels
undergo cytoskeleton based Targeted Delivery to cardiac intercalated discs. Recently, we found an
endogenous truncated isoform of Cx43, the alternatively translated GJA1-20k, which is essential to full
length Cx43 forward trafficking and can rescue ischemia induced defects in Cx43 gap junction
localization. Our studies reveal that GJA1-20k is a critical molecule for channel and organelle
movement. Understanding the molecular details of its role in cardiac muscle cells will reveal
fundamental mechanisms of channel localization and also facilitate translational use of this molecule
into novel and clinically important therapeutic strategies.
The objective of this application is to explore the molecular mechanisms by which GJA1-20k
organizes trafficking highways. Our central hypothesis is that GJA1-20k, which increases during
episodes of myocardial stress, is a powerful cytoskeleton actin nucleator that builds the dynamic
trafficking highways essential for Cx43 gap junction delivery.
Our expertise in ion channel trafficking and identification of GJA1-20k, as well as our cell
biological tools and the new mouse model we generated for this proposal, allow us to successfully carry
out the planned experiments by pursuing two specific aims: 1) Is GJA1-20k essential to the formation of
Cx43 gap junctions in vivo? 2) Is GJA1-20k an actin nucleator, capable of patterning cytoskeleton
pathways for channel delivery?
Once successfully completed, the expected outcomes are to identify that GJA1-20k is a vital
cardiomyocyte protein whose mechanism of action is inherently linked to the actin and microtubule
cytoskeleton, is important in baseline healthy heart, and essential during times of stress. Such results
are expected to have a positive impact because we will have introduced a new therapeutic approach
(exogenous GJA1-20k) to limit pathologic trafficking in arrhythmogenic disease. At the same time, and
perhaps of even more long-term consequence, the studies will help resolve a fundamental unsolved
mystery in the biology of protein trafficking which is how membrane proteins are delivered directly to
their respective subdomain.
离子通道功能紊乱是突发性心律失常的一个基本方面
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robin M Shaw其他文献
Robin M Shaw的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robin M Shaw', 18)}}的其他基金
Unlocking Trafficking Specificity for Cx43 Gap Junctions
解锁 Cx43 间隙连接的贩运特异性
- 批准号:
10613875 - 财政年份:2020
- 资助金额:
$ 38.13万 - 项目类别:
A New Non-Canonical Role for an Alternatively Translated Ion Channel Protein
替代翻译的离子通道蛋白的新非典型作用
- 批准号:
9376618 - 财政年份:2017
- 资助金额:
$ 38.13万 - 项目类别:
A New Non-Canonical Role for an Alternatively Translated Ion Channel Protein
替代翻译的离子通道蛋白的新非典型作用
- 批准号:
10092407 - 财政年份:2017
- 资助金额:
$ 38.13万 - 项目类别:
Novel Mechanisms of Cardiac Ion Channel Regulation
心脏离子通道调节的新机制
- 批准号:
8823481 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
Gap Junction Trafficking to and within the Plasma Membrane
间隙连接运输到质膜和质膜内
- 批准号:
7661737 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
Novel Mechanisms of Cardiac Ion Channel Regulation
心脏离子通道调节的新机制
- 批准号:
8966027 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
Gap Junction Trafficking to and within the Plasma Membrane
间隙连接运输到质膜和质膜内
- 批准号:
8706447 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
Gap Junction Trafficking to and within the Plasma Membrane
间隙连接运输到质膜和质膜内
- 批准号:
7806535 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
Gap Junction Trafficking to and within the Plasma Membrane
间隙连接运输到质膜和质膜内
- 批准号:
8043581 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
Gap Junction Trafficking to and within the Plasma Membrane
间隙连接运输到质膜和质膜内
- 批准号:
8443871 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别: